LOW-GRADE SEROUS OVARIAN CANCER IS
Low-Grade Serous Ovarian Cancer (LGSOC) Resources
New treatments are being studied in clinical trials right now.
This is where you’ll find the latest information about clinical trials, articles about treatment, and news about all things related to low-grade serous ovarian cancer (also known as LGSOC).
Bookmark this page and come back often so you don’t miss out on new developments in the treatment of LGSOC.
New treatments are being studied in clinical trials right now.
This is where you’ll find the latest information about clinical trials, articles about treatment, and news about all things related to low-grade serous ovarian cancer (also known as LGSOC).
Bookmark this page and come back often so you don’t miss out on new developments in the treatment of LGSOC.
Clinical trial finder
Stay up to date on clinical trials for LGSOC through these websites:
Search for “low grade” when using the OCRA (Ovarian Cancer Research Alliance) clinical trial finder.
Clinical trial finder
Stay up to date on clinical trials for LGSOC through these websites:
Search for “low grade” when using the OCRA (Ovarian Cancer Research Alliance) clinical trial finder.
LGSOC Patient Impact Survey Results
We are pleased to present the results from the LGSOC Patient Impact Survey, a first-of-its-kind, multi-national survey among women diagnosed with low-grade serous ovarian cancer (LGSOC). View survey details, including methodology, audience demographics, survey data and more.
Patient Webinar: Let’s Talk About Clinical Trials
Hear from leading gynecologic oncologist, Dr. Jubilee Brown, on recent progress in research evaluating treatments for LGSOC. Dr. Brown also discusses the importance of clinical trials and resources for finding them.
News about low-grade serous ovarian cancer
Voices of LGSOC Report
Apr 12, 2024 | STAAR Ovarian Cancer Foundation
25-Year-Old with Ovarian Cancer Reveals Symptoms Dismissed by Doctors
Nov 28, 2023 | People.com
Woman, 25, with ovarian cancer recalls symptoms that doctors dismissed: ‘You’re fine’
Nov 27, 2023 | Today.com
Low-Grade Serous Ovarian Cancer 2023 Update
Nov 27, 2023 | World Ovarian Cancer Coalition
Externally-led patient-focused drug development (PFDD) meeting for LGSOC
Oct 13, 2023 | STAAR Ovarian Cancer Foundation
How one woman’s rare type of ovarian cancer was almost overlooked
Mar 23, 2023 | SF Gate
Verastem’s new campaigns aims to make distinctions in rare type of ovarian cancer
Mar 17, 2023 | Endpoints News
New Verastem campaign highlights personalized meds in rare ovarian cancer
Mar 16, 2023 | Fierce Pharma
Ovarian Cancer Awareness – Funding Is Crucial To Increasing Survival
Sep 19, 2022 | Health Professional Radio
Rare Ovarian Cancer Awareness Campaign 2022
Jun 16, 2022 | Health Professional Radio
News about low-grade serous ovarian cancer
How one woman’s rare type of ovarian cancer was almost overlooked
Mar 23, 2023 | SF Gate
Verastem’s new campaigns aims to make distinctions in rare type of ovarian cancer
Mar 17, 2023 | Endpoints News
New Verastem campaign highlights personalized meds in rare ovarian cancer
Mar 16, 2023 | Fierce Pharma
Ovarian Cancer Awareness – Funding Is Crucial To Increasing Survival
Sep 19, 2022 | Health Professional Radio
Rare Ovarian Cancer Awareness Campaign 2022
Jun 16, 2022 | Health Professional Radio